Balancing MAGA and MIGA
While the PILLS Act, aims for “strategically incentivising reshoring of…
Interviews
India is rising from a CDMO perspective when it comes to biologics
Bill Coyle, principal, ZS, discusses India's growing role in biologics from a CDMO perspective and how AI is shaping pharma.…
We built the CoviRx database through BITS Pilani to help identify drugs that could be repurposed for…
Professor Seshadri Vasan, Honorary Professor of Medical and Health Sciences at Edith Cowan University (Australia) and University…
India’s biopharma industry needs to become a little bit more ambitious
In a free wheeling conversation with Viveka Roychowdhury, Dr Dhananjay Patankar, biopharma consultant, explains why Indian…
